What is EPZM's gross margin?

Epizyme (EPZM) has a gross margin of 81% and a net margin of -152%.

What is EPZM's P/E ratio?

Track Epizyme (EPZM) P/E ratio, ROE, and valuation metrics over time.

Where can I see EPZM's full financials?

See Epizyme (EPZM) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Epizyme (EPZM) Financials — Revenue, Earnings, Cash Flow

$1.47

Last traded 2022-08-11 — delisted

NASDAQ · Healthcare · Biotechnology

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$53M

Revenue

+62.7% YoY

$-214M

Net Income

+16.8% YoY

$-209M

Free Cash Flow

+8.6% YoY

81.1%

Gross Margin

-108.1%

Op. Margin

-151.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-902.7%

ROA-69.3%

ROIC-203.4%

Valuation

P/E-0.6

P/B-7.2

EV/EBITDA-1.9

Leverage

Debt/Equity-11.72

Current Ratio5.35

Interest Cov.-7.6x

Quality Scores

Piotroski F4/9

Altman Z-7.94

Beneish M-1.71